Cronos Group Inc

NASDAQ:CRON USA Drug Manufacturers - Specialty & Generic
Market Cap
$981.74 Million
Market Cap Rank
#10145 Global
#4750 in USA
Share Price
$2.59
Change (1 day)
+1.97%
52-Week Range
$1.62 - $3.27
All Time High
$23.70
About

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Cronos Group Inc (CRON) - Total Assets

Latest total assets as of December 2025: $1.20 Billion USD

Based on the latest financial reports, Cronos Group Inc (CRON) holds total assets worth $1.20 Billion USD as of December 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Cronos Group Inc - Total Assets Trend (2013–2025)

This chart illustrates how Cronos Group Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Cronos Group Inc - Asset Composition Analysis

Current Asset Composition (December 2025)

Cronos Group Inc's total assets of $1.20 Billion consist of 78.9% current assets and 21.1% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 66.1%
Accounts Receivable $57.20 Million 4.8%
Inventory $46.75 Million 3.9%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $8.89 Million 0.7%
Goodwill $66.48 Million 5.6%

Asset Composition Trend (2013–2025)

This chart illustrates how Cronos Group Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Cronos Group Inc's current assets represent 78.9% of total assets in 2025, an increase from 2.9% in 2013.
  • Cash Position: Cash and equivalents constituted 66.1% of total assets in 2025, up from 0.6% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 0.0% in 2013.
  • Asset Diversification: The largest asset category is goodwill at 5.6% of total assets.

Cronos Group Inc Competitors by Total Assets

Key competitors of Cronos Group Inc based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Cronos Group Inc - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.01 - 0.16

Lower asset utilization - Cronos Group Inc generates 0.16x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -28.34% - 55.80%

Negative ROA - Cronos Group Inc is currently not profitable relative to its asset base.

Cronos Group Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 19.59 18.84 4.36
Quick Ratio 18.62 18.17 4.21
Cash Ratio 0.00 0.00 0.00
Working Capital $895.90 Million $ 886.41 Million $ 1.28 Billion

Cronos Group Inc - Advanced Valuation Insights

This section examines the relationship between Cronos Group Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.89
Latest Market Cap to Assets Ratio 0.43
Asset Growth Rate (YoY) 2.6%
Total Assets $1.20 Billion
Market Capitalization $513.53 Million USD

Valuation Analysis

Below Book Valuation: The market values Cronos Group Inc's assets below their book value (0.43 x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Cronos Group Inc's assets grew by 2.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Cronos Group Inc (2013–2025)

The table below shows the annual total assets of Cronos Group Inc from 2013 to 2025.

Year Total Assets Change
2025-12-31 $1.20 Billion +2.64%
2024-12-31 $1.17 Billion +2.28%
2023-12-31 $1.14 Billion -6.00%
2022-12-31 $1.21 Billion -13.22%
2021-12-31 $1.40 Billion -27.42%
2020-12-31 $1.93 Billion -7.88%
2019-12-31 $2.09 Billion +990.40%
2018-12-31 $191.71 Million +138.62%
2017-12-31 $80.34 Million +151.71%
2016-12-31 $31.92 Million +200.82%
2015-12-31 $10.61 Million +23.78%
2014-12-31 $8.57 Million +565.74%
2013-12-31 $1.29 Million --